Relative effects of dihydropyridine L-type calcium channel antagonism on biliary, duodenal, and vascular tissues: An In Vivo and In Vitro analysis in Australian brush-tailed possum

Digestive Diseases and Sciences

Volumn 47, Issue 9, 2002, Pages 2029-2036

  Craig, A G ^a   Tottrup, A ^b   Toouli, J ^a   Saccone, G T P ^a  

^a FLINDERS UNIVERSITY   (Australia)

^b AARHUS UNIVERSITY HOSPITAL   (Denmark)

Author keywords

Functional abdominal pain; Nifedipine; Sphincter of Oddi; Sphincter of Oddi dysfunction

Indexed keywords

ADALAT OROS; CALCIUM CHANNEL L TYPE; CARBACHOL; DIHYDROPYRIDINE; NICARDIPINE; NORADRENALIN; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DRUG EFFECT; DUODENUM; FEMALE; GALLBLADDER; HEPATOBILIARY SYSTEM; MALE; MANOMETRY; NONHUMAN; ODDI SPHINCTER; PRIORITY JOURNAL; VASCULAR TISSUE;

ANIMALS; BLOOD PRESSURE; CALCIUM CHANNEL AGONISTS; CALCIUM CHANNEL BLOCKERS; CALCIUM CHANNELS, L-TYPE; DUODENUM; FEMALE; GALLBLADDER; MALE; MANOMETRY; NICARDIPINE; NIFEDIPINE; OPOSSUMS; SPHINCTER OF ODDI;

EID: 0036714059     PISSN: 01632116     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1019620812128     Document Type: Article

References (32)

1. Mechanism of action of calcium-channel-blocking agents
2. Adverse reactions with calcium antagonists
3. Calcium channels in smooth muscle
4. Esophageal motility disorders and their response to calcium channel antagonists. The sphinx revisited
5. Efficacy of nifedipine therapy in patients with sphincter of Oddi dysfunction: A prospective, double-blind, randomized, placebo-controlled, cross over trial
6. Nifedipine for suspected type II sphincter of Oddi dyskinesia
7. Diagnosis and treatment of sphincter of Oddi dysfunction
8. Erythromycin and motilin stimulate sphincter of Oddi motility and inhibit trans-sphincteric flow in the Australian possum
9. The nifedipine gastrointestinal therapeutic system (GITS). Evaluation of pharmaceutical, pharmacokinetic and pharmacological properties
10. Pharmacokinetics and pharmacodynamics of nifedipine infusion in normal volunteers
11. Mechanical properties of isolated human esophageal smooth muscle
12. Motilin and erythromycin enhance the in vitro contractile activity of the sphincter of Oddi of the Australian brush-tailed possum
13. Functional disorders of the biliary tract and pancreas
14. Manometric disorders in patients with suspected sphincter of Oddi dysfunction
15. Effect of nifedipine on the motility of the sphincter of Oddi and small bowel of the opossum
16. Effects of Ca blocking agents on canine sphincter of Oddi
17. Effect of nifedipine on sphincter of Oddi motor activity: Studies in healthy volunteers and patients with biliary dyskinesia
18. Controlled study of the effect of nicardipine and ceruletide on the sphincter of Oddi
19. Cardiovascular pharmacology of nicardipine in animals
20. Differential relaxing response of various arterial smooth muscles of dogs to nifedipine
21. Postcholecystectomy pain syndrome: Pathophysiology of abdominal pain in sphincter of Oddi type III
22. Small bowel dysmotility in patients with postcholecystectomy sphincter of Oddi dysfunction
23. Intestinal dysmotility in patients with sphincter of Oddi dysfunction. A reason for failed response to sphincterotomy
24. Nifedipine inhibits cholecystokinin-induced gallbladder contraction
25. Inhibitory effect of nifedipine on cholecystokinin-induced gallbladder contraction in man
26. Effect of nifedipine on interdigestive gallbladder volume and postprandial gallbladder emptying in man
27. Cholesterol gallstone formation in man and potential treatments of the gallbladder motility defect
28. Regional selectivity of calcium blockers at intestinal level
29. 2+ antagonists on spontaneous motility from sheep duodenum
30. 2+ channel antagonists in guinea-pig normal and skinned gall bladder
31. Subunit-dependent modulation of recombinant L-type calcium channels. Molecular basis for dihydropyridine tissue selectivity